BALTIMORE–(BUSINESS WIRE)– EMIT IMAGING, Inc. (“EMIT”), the leader in Cryo-Fluorescence Tomography (CFT), is proud to announce a project with the MIT Koch Institute for Integrative Cancer Research to enhance EMIT’s novel 3D imaging technology. The project will incorporate the Koch Institute’s research-based experiences into CFT workflow and method improvements, allowing for greater accuracy and efficiency in studying cancer and other diseases.